Dr. Tyrone C. Malloy: Contraception

Women’s Health-

Contraception Continued

A multi-center, open-label, single-arm study to assess the efficacy and safety of the oral contraceptive XXXXX in a flexible extended regimen in healthy females for 1 year

Principal Investigator

Sponsor: Bayer HealthCare Pharmaceuticals

A multi-center, double-blind, randomized,  placebo-controlled study to determine the lowest effective does of oral XXX for the relief of moderate to severe vasomotor symptoms in postmenopausal women over a treatment period of 12 weeks

Principal Investigator

Sponsor: Bayer HealthCare Pharmaceuticals

A multi-center, double-blind, double-dummy, randomized, parallel group study to evaluate cycle control, bleeding patter, blood pressure, lipid and carbohydrate metabolism of the transdermal contraceptive patch XXX in a 21-day regimen for 7 cycles

Principal Investigator

Sponsor: Bayer Healthcare Pharmaceuticals

An Open Label, Randomized, Comparator-Controlled Study of the Contraceptive Efficacy of X Oral Tablets Administered for 24 Days of a 28-day Cycle

                                                Principal Investigator                                                

                                                Sponsor: Warner Chilcott

An Open Label, Study of the Contraceptive Efficacy of an Extended Regimen of XXXX and XXX

Principal Investigator

Sponsor: Warner Chilcott 

                                                A multicenter, open-label study to evaluate the efficacy and safety of a combination oral contraceptive regimen XX for the prevention of pregnancy in women

Principal Investigator

Sponsor: Duramed Research, Inc. 

A Multicenter, Open-Label, Randomized Study of the Contraceptive Efficacy and Safety of XXX Gel Compared to XXX Vaginal Gel

Principal Investigator

Sponsor: Evofem, Inc